Molecular Characterization of Murine Pancreatic Phospholipase A[sub 2]

Mandal, Asim K.; Zhang, Zhongjian; Chou, Janice Y.; Zimonjic, Drazen; Keck, Catherine L.; Popescu, Nicolae; Mukherjee, Anil B.
March 2001
DNA & Cell Biology;Mar2001, Vol. 20 Issue 3, p149
Academic Journal
The pancreatic secretory phospholipase A[sub 2] (sPLA[sub 2]IB) is considered to be a digestive enzyme, although it has several important receptor-mediated functions. In this study, using the newly isolated murine sPLA[sub 2]IB cDNA clone as a probe, we demonstrate that in addition to the pancreas, the sPLA[sub 2]IB mRNA was expressed in extrapancreatic organs such as the liver, spleen, duodenum, colon, and lungs. We also demonstrate that sPLA[sub 2]IB mRNA expression was detectable from the 17[sup th] day of gestation in the developing mouse fetus, coinciding with the time of completion of differentiation of the pancreas. Furthermore, the mRNA expression pattern of sPLA[sub 2]IB was distinct from those of sPLA[sub 2]IIA and cPLA[sub 2] in various tissues examined. The murine sPLA[sub 2]IB gene structure is well conserved, consistent with findings in other mammalian species, and this gene mapped to the region of mouse chromosome 5F1-G1.1. Taken together, our results suggest that sPLA[sub 2]IB plays important roles both in the pancreas and in extrapancreatic tissues and that in the mouse, its expression is developmentally regulated.


Related Articles

  • The Secretory Phospholipase A2 Gene is Required for Gastroesophageal Reflux-Related Changes in Murine Esophagus. Babu, Ashok; Mauchley, David; Xianzhong Meng; Banerjee, Anirban M.; Gamboni-Robertson, Fabia; Fullerton, David A.; Weyant, Michael J. // Journal of Gastrointestinal Surgery;Dec2009, Vol. 13 Issue 12, p2212 

    Background The initial response of esophageal mucosa to gastroduodenal reflux is inflammation and hyperplasia. Secretory phospholipase A2 (sPLA2) is a known mediator of gut inflammation, and its levels are increased in Barrett's esophagus. We hypothesized that the sPLA2 gene is required to...

  • Nonbactericidal secreted phospholipase A2s are potential anti-inflammatory factors in the mammary gland. Seroussi, Eyal; Klompus, Shelly; Silanikove, Maayan; Krifucks, Oleg; Shapiro, Fira; Gertler, Arieh; Leitner, Gabriel // Immunogenetics;Dec2013, Vol. 65 Issue 12, p861 

    The recent burst of duplication and divergence of the bovine PLA2G2D genes is considered typical of immune response genes, and it was recently shown that PLA2G2D is abundantly expressed in mouse leukocytes and acts as an immunosuppressive phospholipase. Analysis of 1,143 Holstein bulls indicated...

  • iPLAβ Knockout Mouse, a Genetic Model for Progressive Human Motor Disorders, Develops Age-Related Neuropathology. Blanchard, Helene; Taha, Ameer; Cheon, Yewon; Kim, Hyung-Wook; Turk, John; Rapoport, Stanley // Neurochemical Research;Aug2014, Vol. 39 Issue 8, p1522 

    Calcium-independent phospholipase A group VIa (iPLAβ) preferentially releases docosahexaenoic acid (DHA) from the sn- 2 position of phospholipids. Mutations of its gene, PLA2G6, are found in patients with several progressive motor disorders, including Parkinson disease. At 4 months, PLA2G6...

  • Suramin inhibits the early effects of PLA2 neurotoxins at mouse neuromuscular junctions: A twitch tension study. Fathi, Behrooz; Harvey, Alan L; Rowan, Edward G // Journal of Venom Research;Jun2011, Vol. 2, p6 

    Several phospholipase A2 (PLA2) neurotoxins from snake venoms can affect acetylcholine release at the neuromuscular junction. In isolated nerve-muscle preparations three distinct phases have been described for this phenomenon: An initial transient decrease in twitch tension; a second...

  • Genetic interactions between a phospholipase A2 and the Rim101 pathway components in S. cerevisiae reveal a role for this pathway in response to changes in membrane composition and shape. Mattiazzi, M.; Jambhekar, A.; Kaferle, P.; DeRisi, J. L.; Križaj, I.; Petrovič, U. // Molecular Genetics & Genomics;Jun2010, Vol. 283 Issue 6, p519 

    Modulating composition and shape of biological membranes is an emerging mode of regulation of cellular processes. We investigated the global effects that such perturbations have on a model eukaryotic cell. Phospholipases A2 (PLA2s), enzymes that cleave one fatty acid molecule from membrane...

  • The effects of beta2 adrenergic receptor gene polymorphism in lipid profiles. Wei-Tsung Kao; Yung-Chieh Yen; For-Wey Lung // Lipids in Health & Disease;2008, Vol. 7, Special section p1 

    Background: Explore the interaction between apolipoprotein E (Apo E), phospholipase A2 (PLA2) and β2 adrenergic receptor (β2-AR) gene polymorphisms and lipid profiles in an elderly Chinese population. Methods: Five hundred subjects aged 65 to 74 years were randomly selected from a...

  • Genome-Wide Association Study of Lp-PLA2 Activity and Mass in the Framingham Heart Study. Suchindran, Sunil; Rivedal, David; Guyton, John R.; Milledge, Tom; Xiaoyi Gao; Benjamin, Ashlee; Rowell, Jennifer; Ginsburg, Geoffrey S.; McCarthy, Jeanette J. // PLoS Genetics;Apr2010, Vol. 6 Issue 4, p1 

    Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an emerging risk factor and therapeutic target for cardiovascular disease. The activity and mass of this enzyme are heritable traits, but major genetic determinants have not been explored in a systematic, genome-wide fashion. We carried out a...

  • Molecular and functional characterization of polymorphisms in the secreted phospholipase A2 group X gene: relevance to coronary artery disease. Gora, Sarah; Perret, Claire; Jemel, Ikram; Nicaud, Viviane; Lambeau, Gérard; Cambien, François; Ninio, Ewa; Blankenberg, Stefan; Tiret, Laurence; Karabina, Sonia-Athina // Journal of Molecular Medicine;Jul2009, Vol. 87 Issue 7, p723 

    Among secreted phospholipases A2 (sPLA2s), human group X sPLA2 (hGX sPLA2) is emerging as a novel attractive therapeutic target due to its implication in inflammatory diseases. To elucidate whether hGX sPLA2 plays a causative role in coronary artery disease (CAD), we screened the human PLA2G10...

  • Association between BanI genotype and increased phospholipase A2 activity in schizophrenia. Barbosa, Nadia R.; Junquerira, Ricardo M.; Vallada, Homero P.; Gattaz, Wagner F. // European Archives of Psychiatry & Clinical Neuroscience;Sep2007, Vol. 257 Issue 6, p340 

    Phospholipases A2 (PLA2) are a family of key enzymes in the metabolism of membrane phospholipids. Several studies reported on increased blood and brain PLA2 activity in schizophrenia, which suggest a disordered phospholipid metabolism in the disease. In addition, a genetic variant of a cytosolic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics